TY  - GEN
AU  - Anderson,Amy E
AU  - Lorenzi,Alice R
AU  - Pratt,Arthur
AU  - Wooldridge,Tom
AU  - Diboll,Julie
AU  - Hilkens,Catharien M U
AU  - Isaacs,John D
TI  - Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses
SN  - 1462-0332
PY  - 2012///1002
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Arthritis, Rheumatoid
KW  - complications
KW  - B-Lymphocytes
KW  - immunology
KW  - CD5 Antigens
KW  - Case-Control Studies
KW  - Cohort Studies
KW  - Female
KW  - Flow Cytometry
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunity
KW  - physiology
KW  - Immunophenotyping
KW  - Influenza Vaccines
KW  - administration & dosage
KW  - Lymphocyte Count
KW  - Lymphocyte Depletion
KW  - Lymphopenia
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - T-Lymphocytes
KW  - Thymus Gland
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/rheumatology/kes038
ER  -